Covered recipient · General Payments record
STACEY E HOGROE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$723.76
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $435.81 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $239.97 | 2 |
| Corcept Therapeutics | $95.39 | 2 |
| Insulet Corporation | $35.16 | 2 |
| Embecta Corp. | $22.81 | 1 |
| Xeris Pharmaceuticals, Inc. | $16.13 | 1 |
| Novo Nordisk AS | $14.61 | 1 |
| CeQur Corporation | $11.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $139.96 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125341847 | CMS |
| Abbott Laboratories | $100.01 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125341849 | CMS |
| CeQur Corporation | $11.74 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099650969 | CMS |
| Corcept Therapeutics | $18.12 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117733660 | CMS |
| Corcept Therapeutics | $77.27 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117733712 | CMS |
| Embecta Corp. | $22.81 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144991535 | CMS |
| Insulet Corporation | $19.95 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116803192 | CMS |
| Insulet Corporation | $15.21 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116803190 | CMS |
| Novo Nordisk Inc | $14.61 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100394758 | CMS |
| Xeris Pharmaceuticals, Inc. | $16.13 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144639020 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.